Esophagitis: clinical and endoscopic assessment of sucralfate therapy.
dc.contributor.author | Chopra, B K | en_US |
dc.contributor.author | Kazal, H L | en_US |
dc.contributor.author | Mittal, P K | en_US |
dc.contributor.author | Sibia, S S | en_US |
dc.date.accessioned | 1991-03-01 | en_US |
dc.date.accessioned | 2009-05-29T05:42:41Z | |
dc.date.available | 1991-03-01 | en_US |
dc.date.available | 2009-05-29T05:42:41Z | |
dc.date.issued | 1991-03-01 | en_US |
dc.description.abstract | Twenty patients with endoscopically proved reflux esophagitis were studied. Each patient was given 1 gm sucralfate 4 times a day for 6 weeks. Clinical and endoscopic assessment of the effects of sucralfate on reflux esophagitis was done. 50% patients became asymptomatic and 60% healed endoscopically. The drug was well tolerated. We conclude that sucralfate is an effective and well tolerated drug for treatment of reflux esophagitis. | en_US |
dc.description.affiliation | Department of Medicine Government Medical College/Rajendra Hospital, Patiala. | en_US |
dc.identifier.citation | Chopra BK, Kazal HL, Mittal PK, Sibia SS. Esophagitis: clinical and endoscopic assessment of sucralfate therapy. Indian Journal of Medical Sciences. 1991 Mar; 45(3): 55-7 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/67967 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.indianjmedsci.org | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Esophagitis, Peptic --diagnosis | en_US |
dc.subject.mesh | Esophagoscopy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Sucralfate --adverse effects | en_US |
dc.title | Esophagitis: clinical and endoscopic assessment of sucralfate therapy. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1